The Claim
Daily supplementation with 3 grams of omega-3 fatty acids for two months has no significant effect on serum levels of C-reactive protein or interleukin-6 in adults with end-stage kidney disease undergoing hemodialysis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 3 grams of omega-3 fatty acids daily for two months does not lower levels of two key markers of inflammation—C-reactive protein and interleukin-6—in adults with end-stage kidney disease who are receiving hemodialysis.
See the scientific wording
Two months of daily omega-3 fatty acid supplementation at 3 grams per day does not significantly reduce serum levels of C-reactive protein or interleukin-6 in adults with end-stage kidney disease undergoing hemodialysis, suggesting that short-term supplementation may not be sufficient to modulate systemic inflammation in this population.
In people with severe kidney failure, the body can't properly use omega-3 fats to make anti-inflammatory signals because the blood is full of toxins that interfere with how cells process these fats, so inflammation doesn't go down even when they take high doses.
What the research says
1 studyThis study gave people on dialysis 3 grams of omega-3s daily for two months and found their inflammation levels didn’t go down — so the claim that this short-term dose doesn’t help reduce inflammation is correct.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.